title: Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease.
authors.affiliation: CAP S Martí, Institut Català de la Salut, Barcelona, Spain. 28448mgm@comb.es
authors.forename: M J
authors.initials: MJ
authors.lastname: Gonzalez-Moneo
authors.forename: M
authors.initials: M
authors.lastname: Simó
authors.forename: M
authors.initials: M
authors.lastname: Pie
authors.forename: D
authors.initials: D
authors.lastname: Rivero
mesh_terms: D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D017028:Caregivers / Q000523:psychology*; D017144:Focus Groups; D006801:Humans; D007406:Interview, Psychological; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy*; D010821:Physicians, Family / Q000523:psychology*
chemical_list: D014150:Antipsychotic Agents